Search clinical trials for: Obinutuzumab with Ibrutinib and Venetoclax
Total 11199 results
-
Bnai Zion Medical CenterTel-Aviv Sourasky Medical CenterRecruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
University of UlmAbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study GroupCompletedLeukemia, Lymphocytic, ChronicGermany
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Grupo Cooperativo de Hemopatías MalignasCompletedB-Cell Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)Mexico
-
Dalian Medical UniversityNot yet recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic CLL Study GroupActive, not recruitingChronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in RemissionNetherlands, Belgium, Denmark, Finland, Norway, Sweden
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Japan
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
Paolo GhiaRecruitingChronic Lymphocytic LeukemiaItaly
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingMantle-Cell LymphomaFrance, Canada, Spain, United States, Hungary, Korea, Republic of, Greece, Australia, Netherlands, Belgium, United Kingdom, Czechia, Germany, Poland, Italy, Turkey, Ukraine
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLeukemia, Lymphocytic, Chronic, B-CellCanada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Niguarda HospitalRecruitingCLL TransformationItaly, Switzerland
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruiting
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Italy, New Zealand, Poland, Spain
-
Craig Portell, MDAbbVieCompletedLymphoma, Mantle-Cell | Recurrent Lymphoma, Mantle-CellUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
Klinikum StuttgartUniversity Hospital FreiburgTerminatedPrimary CNS LymphomaGermany
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Georgetown UniversityAbbVie; Pharmacyclics LLC.; Hackensack Meridian HealthActive, not recruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
German CLL Study GroupCancer Trials Ireland; Stichting Hemato-Oncologie voor Volwassenen Nederland... and other collaboratorsActive, not recruitingChronic Lymphoid LeukemiaSpain, Ireland, Austria, Denmark, Israel, Norway, Germany, Switzerland, Italy, Belgium, Finland, Sweden, Netherlands
-
Peking University People's HospitalBeijing HospitalUnknownLeukemia, Lymphocytic, Chronic, B-Cell
-
MingSight Pharmaceuticals, IncRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Aggressive LymphomaUnited States
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
National Cancer Institute (NCI)Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | B-Cell Lymphoma | Chronic Lymphocytic LymphomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompletedLymphoma, Large B-Cell, DiffuseAustria
-
Juno Therapeutics, a Subsidiary of CelgeneRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small LymphocyticUnited States
-
Weill Medical College of Cornell UniversityGenentech, Inc.; BeiGeneRecruitingLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid TissueFrance
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Dana-Farber Cancer InstituteAbbVie; Pharmacyclics LLC.Active, not recruitingWaldenstrom Macroglobulinemia | MYD88 Gene MutationUnited States
-
Northwell HealthPharmacyclics LLC.TerminatedRichter SyndromeUnited States
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania
-
German CLL Study GroupAbbVie; Hoffmann-La RocheActive, not recruitingChronic Lymphocytic LeucemiaGermany
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Austin I KimAstraZeneca; Genentech, Inc.Recruiting
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingAcute Myeloid Leukemia
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand
-
Paolo GhiaRecruiting
-
Swiss Group for Clinical Cancer ResearchCompletedFollicular LymphomaSwitzerland
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia, AdultChina
-
Memorial Sloan Kettering Cancer CenterAdaptive BiotechnologiesRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States